Simulated Trials to Counter ORAL Survelliance Dr. Jack Cush and Dr. Janet Pope at the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/XF8zlISqKC https://t.co/yXn7KADIdo

Undiagnosed IBD in AxSpA Dr. Eric Dein (Summit, New Jersey) discusses Abstract #0495 presented at the ACR 2023 Convergence meeting in San Diego. https://t.co/l0pAs5u9nY https://t.co/BY5HwRlWXo

Biologics in RA: Mechanisms of Delivery Over Mechanisms of Action? Dr. Aurelie Najm discusses abstract 0838 presented at the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/ffMf0R0ces https://t.co/QCAIrUmdoY

Infections During Treatment of GPA with Rituximab Dr. Richard Conway (Dublin, Ireland) discusses abstract 1584 presented at the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/hBusU8XgMo https://t.co/pHT1ymQ7qR

long head of the biceps tendon is intra-articular but extrasynovial, and widely recognized as an important pain generator, especially in anterior shoulder pain. The biceps-labral complex has been identified and broken down into different regions... https://t.co/asiMiGU6hS https://t.co/PidKTSsEfG

Difficult toTreat PsA: Mainly Difficult to Define! Dr. Aurelie Najm reports on abstract 0777 from the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/mqjhkfJ39B https://t.co/mdE8IrG27T

Reduction of AxSpa-Associated Acute Anterior Uveitis with Certolizumab Acute anterior uveitis (AAU) is the most common extra-musculoskeletal manifestation in axial spondyloarthritis (axSpA), affecting up to 50% of patients in some age groups. https://t.co/HpKk0kUWrb https://t.co/mdaRpVeYI2

Effective Treatments for Rheumatoid Arthritis ILD The ACR guidelines for the diagnosis and management of interstitial lung disease, which includes RA-ILD, has been one of the most controversial topics in the runup to ACR Convergence. https://t.co/OWf6Ip2gEw https://t.co/B6zGtNti3t

Day 2 Report - ACR Plenaries: Changing the Practice of Rheumatology https://t.co/SBFbA40cWu https://t.co/cvbtr2EcJD

Watch: Lupus Nephritis Therapy Paradigm Shift Dr. Yuz Yusof reporting on abstract 0782 at the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/m8SgtnVd95 https://t.co/cSexK2PCb5

IV Secukinumab for AxSpa The FDA recently announced approval for intravenous secukinumab (Cosentyx) for adults with psoriatic arthritis, ankylosing spondylitis, and non-radiographic spondylitis. https://t.co/JhOvPIXOMN https://t.co/GoV62NjSmf

How early is early in psoriatic arthritis? Is there a window of opportunity for treatment in PsA to ensure optimal outcomes? https://t.co/VkfQZpbtKA https://t.co/o2Vf9vRo9s